PMID- 30261922 OWN - NLM STAT- MEDLINE DCOM- 20181102 LR - 20240313 IS - 1756-0500 (Electronic) IS - 1756-0500 (Linking) VI - 11 IP - 1 DP - 2018 Sep 27 TI - Modulation of Ca(V)1.3b L-type calcium channels by M(1) muscarinic receptors varies with Ca(V)beta subunit expression. PG - 681 LID - 10.1186/s13104-018-3783-x [doi] LID - 681 AB - OBJECTIVES: We examined whether two G protein-coupled receptors (GPCRs), muscarinic M(1) receptors (M(1)Rs) and dopaminergic D(2) receptors (D(2)Rs), utilize endogenously released fatty acid to inhibit L-type Ca(2+) channels, Ca(V)1.3. HEK-293 cells, stably transfected with M(1)Rs, were used to transiently transfect D(2)Rs and Ca(V)1.3b with different Ca(V)beta-subunits, allowing for whole-cell current measurement from a pure channel population. RESULTS: M(1)R activation with Oxotremorine-M inhibited currents from Ca(V)1.3b coexpressed with alpha(2)delta-1 and a beta(1b), beta(2a), beta(3), or beta(4)-subunit. Surprisingly, the magnitude of inhibition was less with beta(2a) than with other Ca(V)beta-subunits. Normalizing currents revealed kinetic changes after modulation with beta(1b), beta(3), or beta(4), but not beta(2a)-containing channels. We then examined if D(2)Rs modulate Ca(V)1.3b when expressed with different Ca(V)beta-subunits. Stimulation with quinpirole produced little inhibition or kinetic changes for Ca(V)1.3b coexpressed with beta(2a) or beta(3). However, quinpirole inhibited N-type Ca(2+) currents in a concentration-dependent manner, indicating functional expression of D(2)Rs. N-current inhibition by quinpirole was voltage-dependent and independent of phospholipase A(2) (PLA(2)), whereas a PLA(2) antagonist abolished M(1)R-mediated N-current inhibition. These findings highlight the specific regulation of Ca(2+) channels by different GPCRs. Moreover, tissue-specific and/or cellular localization of Ca(V)1.3b with different Ca(V)beta-subunits could fine tune the response of Ca(2+) influx following GPCR activation. FAU - Roberts-Crowley, Mandy L AU - Roberts-Crowley ML AD - Department of Physiology, Program in Neuroscience, University of Massachusetts Medical School, 55 Lake Ave North, Worcester, MA, 01655, USA. FAU - Rittenhouse, Ann R AU - Rittenhouse AR AUID- ORCID: 0000-0002-7446-230X AD - Department of Physiology, Program in Neuroscience, University of Massachusetts Medical School, 55 Lake Ave North, Worcester, MA, 01655, USA. Ann.Rittenhouse@umassmed.edu. AD - Department of Microbiology and Physiological Systems, Program in Neuroscience, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA, 01605, USA. Ann.Rittenhouse@umassmed.edu. LA - eng GR - R29 NS034195/NS/NINDS NIH HHS/United States GR - R01 NS034195/NS/NINDS NIH HHS/United States GR - T32 NS007366/NS/NINDS NIH HHS/United States GR - NS-34195/NS/NINDS NIH HHS/United States GR - TS-NS07366-09/NH/NIH HHS/United States PT - Journal Article DEP - 20180927 PL - England TA - BMC Res Notes JT - BMC research notes JID - 101462768 RN - 0 (CACNA1D protein, human) RN - 0 (Calcium Channels, L-Type) RN - 0 (Receptor, Muscarinic M1) RN - 0 (Receptors, Dopamine D2) RN - 0 (Receptors, G-Protein-Coupled) RN - SY7Q814VUP (Calcium) SB - IM MH - Calcium MH - Calcium Channels, L-Type/*physiology MH - HEK293 Cells MH - Humans MH - Receptor, Muscarinic M1/*physiology MH - Receptors, Dopamine D2 MH - Receptors, G-Protein-Coupled/*physiology PMC - PMC6161362 OTO - NOTNLM OT - Acetylcholine OT - CaVbeta subunit OT - Dopamine OT - L-type calcium current EDAT- 2018/09/29 06:00 MHDA- 2018/11/06 06:00 PMCR- 2018/09/27 CRDT- 2018/09/29 06:00 PHST- 2018/07/31 00:00 [received] PHST- 2018/09/20 00:00 [accepted] PHST- 2018/09/29 06:00 [entrez] PHST- 2018/09/29 06:00 [pubmed] PHST- 2018/11/06 06:00 [medline] PHST- 2018/09/27 00:00 [pmc-release] AID - 10.1186/s13104-018-3783-x [pii] AID - 3783 [pii] AID - 10.1186/s13104-018-3783-x [doi] PST - epublish SO - BMC Res Notes. 2018 Sep 27;11(1):681. doi: 10.1186/s13104-018-3783-x.